AstraZeneca PLC Files Routine 6-K Disclosure
Ticker: AZN · Form: 6-K · Filed: May 21, 2025 · CIK: 901832
| Field | Detail |
|---|---|
| Company | Astrazeneca PLC (AZN) |
| Form Type | 6-K |
| Filed Date | May 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulatory-filing, foreign-issuer
Related Tickers: AZN
TL;DR
AZN filed a 6-K, just a routine check-in, no big news.
AI Summary
AstraZeneca PLC filed a Form 6-K on May 21, 2025, to report its status as a foreign issuer. The company, headquartered at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom, confirmed it files annual reports under Form 20-F. This filing does not contain specific financial figures or operational updates but serves as a routine disclosure.
Why It Matters
This filing is a standard procedural document for foreign issuers, indicating AstraZeneca's compliance with SEC reporting requirements for the month of May 2025.
Risk Assessment
Risk Level: low — This is a routine administrative filing by AstraZeneca PLC and does not contain new material information that would typically impact risk.
Key Players & Entities
- AstraZeneca PLC (company) — Filer of the Form 6-K
- 001-11960 (company) — Commission File Number for AstraZeneca PLC
- 1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA United Kingdom (company) — Business and mail address of AstraZeneca PLC
- May 2025 (date) — Reporting period for the Form 6-K
- 20250521 (date) — Filing date of the Form 6-K
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K is to serve as a Report of Foreign Issuer for AstraZeneca PLC, indicating its filing status and compliance with SEC regulations for the month of May 2025.
What is AstraZeneca PLC's commission file number?
AstraZeneca PLC's commission file number is 001-11960.
Where is AstraZeneca PLC's principal business address?
AstraZeneca PLC's principal business address is 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom.
Does AstraZeneca PLC file annual reports under Form 20-F or Form 40-F?
AstraZeneca PLC indicated by a check mark that it files annual reports under cover of Form 20-F.
What is the filing date of this Form 6-K?
This Form 6-K was filed on May 21, 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 21, 2025 regarding ASTRAZENECA PLC (AZN).